KraneShares MSCI All China Health Care Index ETF
|
- Description
- Performance
- Comps
- Fundamentals
- Valuation
- Rating
The KraneShares MSCI All China Health Care Index ETF tracks an index of large- and midcap Chinese stocks in the health care sector, weighted by market capitalization. |
Category | Emerging Market Equities |
Fund Sponsor | KraneShares |
Website | kraneshares.com |
Inception date | Jan 31, 2018 |
Assets (mns) | $43 |
Currency | USD |
Expense ratio | 65 bp |
Distributions | Semi-annual |
Regulation | Open-Ended Fund |
Custodian | |
Weighting | Market Cap |
Index replication | |
Uses derivatives | No |
Options available | Yes |
No. of constituents | 63 |
Wgt avg mkt cap (mns) | $14,849 |
Large cap (>$10bn) | 40.8% |
Mid cap ($2-10bn) | 58.0% |
Small cap (<$2bn) | 0.5% |
Developed mkts | 20.3% |
Emerging mkts | 79.7% |
SHENZHEN MINDRAY BIO-MEDICAL ELECT | 9.0 % |
JIANGSU HENGRUI MEDICINE CO., LTD. | 7.2 % |
BEIGENE, LTD. | 5.0 % |
CHINA PHARMACEUTICAL GROUP | 4.2 % |
INNOVENT BIOLOGICS, INC. | 3.9 % |
WUXI BIOLOGICS (CAYMAN) INC. | 3.6 % |
ZHANGZHOU PIENTZEHUANG PHARMACEUTI | 3.5 % |
WUXI APPTEC CO., LTD. CLASS A | 2.8 % |
LEGEND BIOTECH CORPORATION SPONSOR | 2.7 % |
AIER EYE HOSPITAL GROUP CO., LTD. | 2.6 % | Total | 44.5 % |
---|
CHINA | 88.7 % | |
HONG KONG | 7.5 % | |
UNITED STATES | 2.7 % |
HISTORICAL PERFORMANCE
Custom date range | Compare to | ||
thru |
Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
-7.8% | -11.5% | -4.5% | -- | -5.6% |
versus... | Beta | R-squared |
S&P500 | 0.31 | 3% |
MSCI EAFE | 0.62 | 13% |
MSCI Emg. Mkts. | 0.96 | 30% |
Recent close | $15.22 |
30d moving avg. | $16.10 |
Annualized volatility | 30.7% |
Short interest (ETF) | 1.9% |
Relative strength (RSI) | 49 |
Avg. volume (thou.) | 25 |
Turnover | 0.9% |
Bid/Ask (% of price) | 0.87% |
ADV underlying (mns) | $4,871 |
FINDING ALTERNATIVE FUNDS
Below is a list of 144 potential alternatives to the KraneShares MSCI All China Health Care Index ETF ETF based on the alternatives' overlap in portfolio holdings with KURE. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
Benchmark ticker: | KURE | Expense: | 65 bp | ALTAR Score™: | 4.3% |
Ticker | Fund Name |
Overlap1 vs KURE (%) |
Expense ratio (bp) |
Savings vs KURE (bp) |
ALTAR Score™ (%) |
ALTAR vs KURE (%) |
CXSE | WisdomTree China ex-State-Owned Enterprises Fund | 8.1 | 32 | 33 | 6.1 | +1.8 |
KBA | KraneShares Bosera MSCI China A 50 Connect Index ETF | 6.8 | 55 | 10 | 8.5 | +4.2 |
ASHR | Xtrackers Harvest CSI 300 China A-Shares ETF | 6.4 | 65 | 0 | 7.9 | +3.6 |
CNYA | iShares MSCI China A ETF | 5.3 | 60 | 5 | 8.0 | +3.7 |
IDNA | iShares Genomics Immunology and Healthcare ETF | 5.0 | 47 | 18 | -4.3 | -8.6 |
RAYC | Rayliant Quantamental China Equity ETF | 4.8 | 80 | -15 | 8.6 | +4.3 |
OZEM | Roundhill GLP-1 & Weight Loss ETF | 4.3 | 59 | 6 | -0.8 | -5.1 |
KALL | KraneShares MSCI All China Index ETF | 4.2 | 49 | 16 | 9.0 | +4.7 |
ASHS | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF | 4.1 | 65 | 0 | 6.2 | +1.9 |
EMDV | ProShares MSCI Emerging Markets Dividend Growers ETF | 4.1 | 60 | 5 | 9.8 | +5.5 |
AFTY | Pacer CSOP FTSE China A50 ETF | 4.0 | 70 | -5 | 9.0 | +4.7 |
GNOM | Global X Genomics & Biotechnology ETF | 3.9 | 50 | 15 | -5.6 | -9.9 |
KDIV | KraneShares S&P Pan Asia Dividend Aristocrats Index ETF | 3.8 | 68 | -3 | 8.2 | +4.0 |
FLCH | Franklin FTSE China ETF | 3.5 | 19 | 46 | 8.8 | +4.5 |
MCHI | iShares MSCI China ETF | 3.4 | 59 | 6 | 8.4 | +4.1 |
KSTR | KraneShares SSE STAR Market 50 Index ETF | 3.3 | 89 | -24 | 2.1 | -2.2 |
JCHI | JPMorgan Active China ETF | 3.1 | 65 | 0 | 8.0 | +3.7 |
THNR | Amplify Weight Loss Drug & Treatment ETF | 3.1 | 59 | 6 | 5.2 | +0.9 |
GXC | SPDR S&P China ETF | 2.8 | 59 | 6 | 8.3 | +4.0 |
EDIV | SPDR S&P Emerging Markets Dividend ETF | 2.8 | 49 | 16 | 12.0 | +7.7 |
MCH | Matthews China Active ETF | 2.8 | 79 | -14 | 5.4 | +1.1 |
MEDI | Harbor Health Care ETF | 2.7 | 80 | -15 | 1.4 | -2.9 |
FMED | Fidelity Disruptive Medicine ETF | 2.7 | 50 | 15 | -0.4 | -4.6 |
FCA | First Trust China AlphaDEX Fund | 2.2 | 80 | -15 | 16.2 | +11.9 |
ESGE | iShares ESG Aware MSCI EM ETF | 2.0 | 25 | 40 | 7.1 | +2.8 |
BBP | Virtus LifeSci Biotech Products ETF | 1.9 | 79 | -14 | 0.0 | -4.3 |
FDEM | Fidelity Emerging Markets Multifactor ETF | 1.8 | 25 | 40 | 12.3 | +8.0 |
BKF | iShares MSCI BIC ETF | 1.7 | 69 | -4 | 6.9 | +2.6 |
JPEM | JPMorgan Diversified Return Emerging Markets Equity ETF | 1.7 | 44 | 21 | 10.6 | +6.3 |
SAGP | Strategas Global Policy Opportunities ETF | 1.6 | 65 | 0 | 5.3 | +1.0 |
FEM | First Trust Emerging Markets AlphaDEX Fund | 1.6 | 80 | -15 | 13.0 | +8.8 |
EMXF | iShares ESG Advanced MSCI EM ETF | 1.6 | 16 | 49 | 6.8 | +2.5 |
LDEM | iShares ESG MSCI EM Leaders ETF | 1.6 | 17 | 48 | 7.6 | +3.4 |
XSOE | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 1.5 | 32 | 33 | 6.2 | +1.9 |
FXI | iShares China Large-Cap ETF | 1.5 | 74 | -9 | 8.2 | +3.9 |
GEM | Goldman Sachs ActiveBeta Emerging Markets Equity ETF | 1.5 | 45 | 20 | 11.0 | +6.7 |
MEM | Matthews Emerging Markets Equity Active ETF | 1.4 | 79 | -14 | 5.4 | +1.1 |
ROAM | Hartford Multifactor Emerging Markets ETF | 1.4 | 44 | 21 | 15.8 | +11.5 |
VIDI | Vident International Equity Strategy ETF | 1.4 | 61 | 4 | 10.2 | +5.9 |
EMSG | Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF | 1.4 | 20 | 45 | 6.8 | +2.5 |
IQDY | FlexShares International Quality Dividend Dynamic Index Fund | 1.3 | 47 | 18 | 9.4 | +5.1 |
EQLT | iShares MSCI Emerging Markets Quality Factor ETF | 1.2 | 35 | 30 | 7.4 | +3.1 |
BMED | Future Health ETF | 1.2 | 85 | -20 | -0.2 | -4.5 |
EEMV | iShares MSCI Emerging Markets Min Vol Factor ETF | 1.2 | 25 | 40 | 6.6 | +2.4 |
CANC | Tema Oncology ETF | 1.1 | 75 | -10 | -3.6 | -7.9 |
CNCR | Range Cancer Therapeutics ETF | 1.1 | 79 | -14 | 0.0 | -4.3 |
AGNG | Global X Aging Population ETF | 1.1 | 50 | 15 | 4.2 | -0.1 |
EEMA | iShares MSCI Emerging Markets Asia ETF | 1.1 | 49 | 16 | 6.5 | +2.2 |
MOTI | VanEck Morningstar International Moat ETF | 1.1 | 58 | 7 | 5.9 | +1.6 |
BHCHX | Baron Health Care Strategy | 1.1 | 75 | -10 | -0.8 | -5.0 |
MINV | Matthews Asia Innovators Active ETF | 1.1 | 79 | -14 | 3.0 | -1.3 |
NUEM | Nuveen ESG Emerging Markets Equity ETF | 1.1 | 36 | 29 | 6.5 | +2.2 |
AAXJ | iShares MSCI All Country Asia ex Japan ETF | 1.0 | 70 | -5 | 6.2 | +1.9 |
QEMM | SPDR MSCI Emerging Markets StrategicFactors ETF | 1.0 | 30 | 35 | 8.1 | +3.8 |
FLAX | Franklin FTSE Asia Ex Japan ETF | 1.0 | 19 | 46 | 6.9 | +2.6 |
GMF | SPDR S&P Emerging Asia Pacific ETF | 1.0 | 49 | 16 | 6.1 | +1.8 |
DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | 1.0 | 41 | 24 | 7.4 | +3.1 |
RODE | Hartford Multifactor Diversified International ETF | 1.0 | 29 | 36 | 11.8 | +7.5 |
DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.9 | 66 | -1 | 10.0 | +5.7 |
EEMX | SPDR MSCI Emerging Markets Fossil Fuel Free ETF | 0.9 | 30 | 35 | 7.3 | +3.0 |
EEM | iShares MSCI Emerging Markets ETF | 0.9 | 69 | -4 | 6.9 | +2.6 |
FEEM | FlexShares ESG & Climate Emerging Markets Core Index ETF | 0.9 | 18 | 47 | 6.8 | +2.5 |
VWO | Vanguard FTSE Emerging Markets ETF | 0.9 | 8 | 57 | 6.9 | +2.6 |
MDEV | First Trust Indxx Medical Devices ETF | 0.8 | 70 | -5 | 4.3 | -0.0 |
AVES | Avantis Emerging Markets Value ETF | 0.8 | 36 | 29 | 11.6 | +7.3 |
UEVM | VictoryShares Emerging Markets Value Momentum ETF | 0.8 | 45 | 20 | 12.3 | +8.0 |
BBEM | JPMorgan BetaBuilders Emerging Markets Equity ETF | 0.8 | 15 | 50 | 7.2 | +3.0 |
BIOPX | Baron Opportunity Retail | 0.8 | 75 | -10 | 1.0 | -3.3 |
IEMG | iShares Core MSCI Emerging Markets ETF | 0.8 | 9 | 56 | 7.5 | +3.2 |
DFAE | Dimensional Emerging Core Equity Market ETF | 0.8 | 35 | 30 | 7.3 | +3.0 |
DFEM | Dimensional Emerging Markets Core Equity 2 ETF | 0.8 | 38 | 27 | 7.8 | +3.5 |
SCHE | Schwab Emerging Markets Equity ETF | 0.7 | 11 | 54 | 7.1 | +2.8 |
XT | iShares Exponential Technologies ETF | 0.7 | 46 | 19 | 4.8 | +0.5 |
ECNS | iShares MSCI China Small-Cap ETF | 0.7 | 59 | 6 | 14.2 | +9.9 |
SPEM | SPDR Portfolio Emerging Markets ETF | 0.7 | 7 | 58 | 7.3 | +3.0 |
INNO | Harbor Disruptive Innovation ETF | 0.7 | 75 | -10 | 1.6 | -2.7 |
AVEM | Avantis Emerging Markets Equity ETF | 0.7 | 33 | 32 | 8.9 | +4.6 |
EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Impr | 0.7 | 15 | 50 | 10.2 | +5.9 |
BKEM | BNY Mellon Emerging Markets Equity ETF | 0.6 | 11 | 54 | 8.4 | +4.1 |
DFEV | Dimensional Emerging Markets Value ETF | 0.6 | 43 | 22 | 11.1 | +6.8 |
EMMF | WisdomTree Emerging Markets Multifactor Fund | 0.6 | 48 | 17 | 8.8 | +4.5 |
JHEM | John Hancock Multifactor Emerging Markets ETF | 0.6 | 49 | 16 | 8.2 | +3.9 |
FPA | First Trust Asia Pacific ex-Japan AlphaDEX Fund | 0.6 | 80 | -15 | 7.6 | +3.3 |
IBB | iShares Biotechnology ETF | 0.6 | 45 | 20 | 0.3 | -4.0 |
JIG | JPMorgan International Growth ETF | 0.6 | 55 | 10 | 4.6 | +0.4 |
CGIE | Capital Group International Equity ETF | 0.6 | 54 | 11 | 4.9 | +0.6 |
EVLU | iShares MSCI Emerging Markets Value Factor ETF | 0.5 | 35 | 30 | 12.4 | +8.1 |
JEMA | JPMorgan ActiveBuilders Emerging Markets Equity ETF | 0.5 | 33 | 32 | 8.2 | +3.9 |
SDG | iShares MSCI Global Sustainable Development Goals ETF | 0.5 | 49 | 16 | 5.6 | +1.4 |
BIGFX | Baron International Growth Retail | 0.5 | 75 | -10 | 3.1 | -1.2 |
PXH | Invesco FTSE RAFI Emerging Markets ETF | 0.5 | 49 | 16 | 12.2 | +8.0 |
FPXI | First Trust International Equity Opportunities ETF | 0.5 | 70 | -5 | 4.9 | +0.6 |
MFEM | PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF | 0.5 | 50 | 15 | 13.0 | +8.7 |
GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.5 | 36 | 29 | 7.8 | +3.5 |
FNDE | Schwab Fundamental Emerging Markets Large Co. Index ETF | 0.4 | 39 | 26 | 12.5 | +8.2 |
TLTE | FlexShares Morningstar Emerging Markets Factor Tilt Index | 0.4 | 59 | 6 | 11.3 | +7.0 |
EMGF | iShares Emerging Markets Equity Factor ETF | 0.4 | 25 | 40 | 8.5 | +4.2 |
DEHP | Dimensional Emerging Markets High Profitability ETF | 0.4 | 41 | 24 | 5.0 | +0.7 |
RFEM | First Trust Riverfront Dynamic Emerging Markets ETF | 0.4 | 95 | -30 | 10.5 | +6.2 |
IGRO | iShares International Dividend Growth ETF | 0.3 | 15 | 50 | 7.5 | +3.3 |
IBBQ | Invesco Nasdaq Biotechnology ETF | 0.3 | 19 | 46 | 0.9 | -3.4 |
VSGX | Vanguard ESG International Stock ETF | 0.3 | 12 | 53 | 6.8 | +2.5 |
UIVM | VictoryShares International Value Momentum ETF | 0.3 | 35 | 30 | 11.0 | +6.7 |
DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.3 | 30 | 35 | 8.0 | +3.7 |
BBAX | JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF | 0.3 | 19 | 46 | 5.4 | +1.1 |
ACWX | iShares MSCI ACWI ex U.S. ETF | 0.3 | 34 | 31 | 7.0 | +2.7 |
CNXT | VanEck ChiNext ETF | 0.3 | 65 | 0 | 4.1 | -0.2 |
VEU | Vanguard FTSE All-World ex-US Index Fund | 0.3 | 8 | 57 | 7.3 | +3.0 |
CWI | SPDR MSCI ACWI ex-US ETF | 0.3 | 30 | 35 | 6.9 | +2.7 |
DGS | WisdomTree Emerging Markets SmallCap Dividend Fund | 0.3 | 58 | 7 | 10.2 | +5.9 |
VXUS | Vanguard Total International Stock ETF | 0.2 | 7 | 58 | 7.2 | +2.9 |
IXUS | iShares Core MSCI Total International Stock ETF | 0.2 | 7 | 58 | 7.2 | +2.9 |
DBAW | Xtrackers MSCI All World ex US Hedged Equity ETF | 0.2 | 41 | 24 | 7.4 | +3.1 |
WRND | IQ Global Equity R&D Leaders ETF | 0.2 | 18 | 47 | 7.5 | +3.2 |
ECON | Columbia Emerging Markets Consumer ETF | 0.2 | 49 | 16 | 7.3 | +3.0 |
ANEW | ProShares MSCI Transformational Changes ETF | 0.2 | 45 | 20 | 3.6 | -0.7 |
GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.2 | 18 | 47 | 7.0 | +2.7 |
ACWV | iShares MSCI Global Min Vol Factor ETF | 0.2 | 20 | 45 | 6.3 | +2.1 |
VIGI | Vanguard International Dividend Appreciation ETF | 0.2 | 15 | 50 | 6.4 | +2.1 |
ACWI | iShares MSCI ACWI ETF | 0.1 | 32 | 33 | 5.3 | +1.0 |
JSTC | Adasina Social Justice All Cap Global ETF | 0.1 | 89 | -24 | 4.9 | +0.6 |
IQSI | IQ Candriam International Equity ETF | 0.1 | 15 | 50 | 6.6 | +2.3 |
VT | Vanguard Total World Stock ETF | 0.1 | 7 | 58 | 5.5 | +1.2 |
NZAC | SPDR MSCI ACWI Climate Paris Aligned ETF | 0.1 | 12 | 53 | 4.8 | +0.5 |
KOMP | SPDR S&P Kensho New Economies Composite ETF | 0.1 | 20 | 45 | 1.0 | -3.3 |
DEM | WisdomTree Emerging Markets High Dividend Fund | 0.1 | 63 | 2 | 18.9 | +14.6 |
VYMI | Vanguard International High Dividend Yield ETF | 0.1 | 22 | 43 | 9.8 | +5.5 |
EWX | SPDR S&P Emerging Markets Small Cap ETF | 0.1 | 65 | 0 | 8.2 | +3.9 |
EEMS | iShares MSCI Emerging Markets Small Cap ETF | 0.1 | 70 | -5 | 7.7 | +3.4 |
FBCG | Fidelity Blue Chip Growth ETF | 0.1 | 59 | 6 | 2.8 | -1.5 |
DEW | WisdomTree Global High Dividend Fund | 0.1 | 58 | 7 | 8.5 | +4.2 |
GSID | Goldman Sachs MarketBeta International Equity ETF | 0.1 | 20 | 45 | 7.0 | +2.7 |
BKIE | BNY Mellon International Equity ETF | 0.1 | 4 | 61 | 7.1 | +2.8 |
GLOF | iShares Global Equity Factor ETF | 0.0 | 20 | 45 | 7.0 | +2.7 |
SPGM | SPDR Portfolio MSCI Global Stock Market ETF | 0.0 | 9 | 56 | 5.4 | +1.1 |
QLVE | FlexShares Emerging Markets Quality Low Volatility Index Fun | 0.0 | 40 | 25 | 8.3 | +4.0 |
FNDC | Schwab Fundamental International Small Co. Index ETF | 0.0 | 39 | 26 | 7.2 | +2.9 |
CRBN | iShares MSCI ACWI Low Carbon Target ETF | 0.0 | 20 | 45 | 5.2 | +0.9 |
DIVI | Franklin International Core Dividend Tilt Index ETF | 0.0 | 9 | 56 | 8.1 | +3.8 |
ONEQ | Fidelity Nasdaq Composite Index ETF | 0.0 | 21 | 44 | 3.8 | -0.5 |
ESGG | FlexShares STOXX Global ESG Select Index Fund | 0.0 | 42 | 23 | 5.1 | +0.8 |
TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt | 0.0 | 39 | 26 | 7.4 | +3.1 |
APIE | ActivePassive International Equity ETF | 0.0 | 45 | 20 | 8.1 | +3.8 |
DNL | WisdomTree Global ex-US Quality Dividend Growth Fund | 0.0 | 42 | 23 | 8.1 | +3.8 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | |
---|---|---|---|---|---|---|---|
Sales per share | ** | ** | ** | ** | ** | ** | ** |
Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share | ** | ** | ** | ** | ** | ** | ** |
Book value per share | ** | ** | ** | ** | ** | ** | ** |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
Long term EPS growth est. | **% | Debt-to-equity | **x | |
Asset turnover | **% | Assets-to-equity | **x |
*Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
2023 | 2024E | 2025E | |
---|---|---|---|
Price-to-sales | ** | ** | ** |
Price-to-earnings | ** | ** | ** |
Price-to-cash flow | ** | ** | ** |
Price-to-growth | ** | ** | ** |
Price-to-book value | ** | ** | ** |
Yield | ** | ** | ** |
Historical valuation trends
Forward multiple: |
KraneShares MSCI All China Health Care Index ETF | |||
Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
UNDERWEIGHT |
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals. |
ALTAR Score™
|
MODERN PORTFOLIO THEORY
|
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|